Interviews

What can we help you find?
New Single-Dose, Intranasal COVID-19 Vaccine May Prevent Transmission, Disease
Pharmacy Times® interviewed Sarah Browne, MD, senior director of vaccine development at Altimmune, on the commencement of a phase 1 clinical trial of a single-dose, intranasal COVID-19 vaccine.
COVID-19 Vaccinations Ramp Up in the Wake of Federal Retail Pharmacy Program
In a recent interview with Pharmacy Times, Council Powell, PharmD, region director with CVS, said pharmacists and technicians are hard at work administering COVID-19 vaccines around the country.
 
Pfizer COVID-19 Vaccine’s Updated Cold Storage Requirements Will Get More Doses in More Arms
Pharmacy Times® interviewed Farah Towfic, PharmD, MBA, the director, CEO operations at US Pharmacopeia, on the FDA’s approval of the Pfizer and BioNTech COVID-19 vaccine’s updated cold storage requirements.
Expert: Johnson & Johnson Vaccine ‘May Be a Vaccine That Many Americans Have Access to Very Easily, Very Close to Their Home’
Amesh Adalja, MD, FIDSA, FACP, FACEP, discussed the distribution prospects for the Johnson & Johnson COVID-19 vaccine in light of it being possible to store it at standard refrigeration temperatures for up to 3 months.
Expert: Johnson & Johnson COVID-19 Vaccine Has Joined Group of Vaccines That Are 'The Path to Reclaiming Our Lives’
Amesh Adalja, MD, FIDSA, FACP, FACEP, a senior scholar at the Johns Hopkins Center for Health Security, discusses how Johnson & Johnson’s COVID-19 vaccine provides effective support in prevention of severe disease and hospitalization.
How an EUA for the Johnson & Johnson’s Single-Dose COVID-19 Vaccine May Impact Vaccine Distribution, Administration
Pharmacy Times® interviewed Amesh Adalja, MD, FIDSA, FACP, FACEP, a senior scholar at the Johns Hopkins Center for Health Security, on how the proposed EUA for Johnson & Johnson’s single-dose vaccine may impact the COVID-19 vaccine distribution and administration process.
The Pandemic May Provide the Infrastructure Necessary to Address the Antimicrobial Resistance Health Crisis
Pharmacy Times® interviewed Kenneth Thorpe, PhD, the former deputy assistant secretary at the HHS during the Clinton administration, on how pandemic preparedness lessons from COVID-19 may help to tackle the antimicrobial resistance health crisis.
A Look at What’s Ahead in the Rapidly Growing Cell Therapy Landscape
Pharmacy Times® interviewed David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property and FDA practice groups, on what may be coming to market in the rapidly growing cell therapy space, and the role pharmacists may play in this emerging landscape.
New Cancer Research Collaboration Seeks to Develop Targeted Radium Therapeutic
Pharmacy Times® interviewed J. David Robertson, PhD, director of University of Missouri Research Reactor, on a new collaboration with Advanced Accelerator Applications International to develop a targeted therapy for certain types of cancerous tumors.
PT Top 3: Pharmacy School Snacks
Crystal Lewis, a third-year pharmacy student at Washington State University, about her top 3 study snacks for pharmacy students. 
Expert Says Biden Administration Must Fully Lean Into Existing Infrastructure for COVID-19 Vaccinations
Pharmacy Times® interviewed Kurt Proctor, PhD, RPh, senior vice president of strategic initiatives at the NCPA, on his outlook on the future of the COVID-19 vaccination rollout under the Biden administration.
Impact of New Once-monthly, Long-acting HIV Regimen on Patient Care
Pharmacy Times® interviewed Susan Swindells, MD, of the University of Nebraska Medical Center, on the impact of the recently FDA-approved once-monthly, long-acting HIV regimen on how providers care for patients with the virus.